Phase 3 Readout~month

Phase 3 Topline: A Multicentre, Open-label Trial in Healthy Volunteers to Assess the Boostability of Three Different

Name: Phase 3 Topline: A Multicentre, Open-label Trial in Healthy Volunteers to Assess the Boostability of Three Different
Start: 2027-06-01

June 1, 2027

Company: Prime Medicine, Inc. (PRME)
Indication: Rabies (Healthy Volunteers)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 3 Topline: A Multicentre, Open-label Trial in Healthy Volunteers to Assess the Boostability of Three Different — PRME Phase 3 Readout | BioSniper